Sanderling Ventures

https://www.sanderling.com

Last activity: 26.11.2016

Active

Sanderling has supported over 90 biomedical companies earning consistently high rates of return on its venture investments.

Mentions

Overview

Investment Type

Venture Capital

Mentions in press and media 19

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Oct 10, 2013	No catheter, no cuff: FDA clears Sotera Wireless’ continuous noninvasive blood pressure technology	The ViSi Mobile System, a wrist-worn monitor that measures vital signs and is designed to be used in ambulatory, non-ICU clinical settings, and was FDA-cleared in 2012. The company also boasts partnerships with Intermountain Health and Refl...
Sep 5, 2013	BDC and FTQ Pour Major Investment into New Montreal Biomedical Fund	Money seems to be flying around Montreal these days. The Business Development Bank of Canada (BDC) and the Fonds de Solidarité du Quebec (FTQ) have announced a $30 million commitment to US-based Sanderling Ventures, an investment firm with ...
Dec 13, 2011	Sotera Wireless Completes $12.2M Series D Financing	Sotera Wireless, Inc., a San Diego CA-based medical device company, completed a $12.2m Series D financing. The round was led by Singapore-based global fund, EDBI, with participation from new investor Cerner Capital and existing investors Sa...
Aug 18, 2010	Cancer drug developer Endocyte files for $86M IPO	Endocyte’s small-molecule drug conjugates “actively target receptors that are over-expressed on diseased cells,” the company said in its registration statement. This targeting enables patients to be treated with highly active drugs or high ...
Aug 4, 2010	Cancer drugmaker Gemin X closes $8M Series E round	It’s unclear when Gemin X will begin its Phase 3 trial, but it’s safe to say it won’t happen this year, a company spokeswoman said. Gemin X’s latest fundraise brings the total amount of equity it’s brought in to $120 million since the compa...
Apr 7, 2010	Torax Medical gets European OK for acid reflux disease device	The device has not yet been cleared for U.S. sales. In September, Torax completed patient enrollment in a “pivotal” clinical trial that could be the springboard for approval by the Food and Drug Administration, according to Mark Stultz, sen...
Apr 7, 2010	Torax Medical wins CE Mark for GERD device	By Brandon Glenn Torax Medical Inc. won CE Mark approval in the European Union for an implantable device that treats patients suffering from acid-reflux disease. The company’s Linx device is intended for patients with gastro-esophageal refl...
Oct 16, 2009	Cancer drug business Endocyte raises $26 million	Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal...
Apr 16, 2008	Xytis gets $7.5M to work on central nervous system disorders	Xytis, a privately-held biotech company based in both the U.S. (Irvine, CA) and Europe (London, England and Nyon, Switzerland) has raised a new round of series B funding. The company specializes in making treatments for patients with centra...
Jul 20, 2007	Novocell: With diabetes study pending, investors pony up another $25M	Novocell, a San Diego embryonic stem-cell company, raised $25 million in a third round of funding. That’s presumably a bit of a letdown for the company, which had previously hoped to pull in as much as $35 million in the round. I wrote earl...
Jul 11, 2007	NeoMend pulls together $6M for wound healing	NeoMend, an Irvine, Calif., biomaterials company focused on wound care, raised $6 million in a third funding round, VentureWire reports (subscription required). Investors included Prospect Venture Partners, Sanderling Ventures and other uni...
Jul 5, 2007	TheraVida raises seed funding for urology research	TheraVida, a new biotech based in San Mateo, Calif., has raised seed funding from Sanderling Ventures, VentureWire reports (subscription required). The company, which doesn’t seem to have a Web site (a possible stub site is here), is resear...
May 4, 2007	PET scanner Naviscan pulls in $15M	Naviscan PET Systems, a San Diego maker of high-resolution positron-emission tomography (PET) scanners, raised $15 million in a third round of funding led by QuestMark Partners. Returning investors included Sanderling Ventures, Mayo Medical...
	Torax Medical gets European OK for acid reflux disease device	Torax Medical Inc. has received regulatory approval from the European Union to sell an implantable device that treats patients suffering from acid reflux disease. The company’s Linx device is intended for patients with gastroesophageal refl...
	No catheter, no cuff: FDA clears Sotera Wireless’ continuous noninvasive blood pressure technology	No more catheter, no more cuff for monitoring patient vital signs? Sotera Wireless announced the FDA has given 510(k) clearance to its continuous non-invasive blood pressure (cNIBP) technology, a new feature of its ViSi Mobile patient monit...
	Cancer drugmaker Gemin X closes $8M Series E round	Gemin X Pharmaceuticals has closed an $8 million Series E round of funding that it will use to prepare for Phase 3 clinical trials of its lung cancer drug. The Malvern, Pennsylvania-based company is in the midst of a Phase 2b trial of its l...
	Cancer drug business Endocyte raises $26 million	WEST LAFAYETTE, Indiana — The cancer drug developer Endocyte has raised $26 million it will use to help complete a study for its ovarian cancer treatment. The company is in the midst of a Phase 2 trial on an ovarian drug that works with wom...
	Cancer drug developer Endocyte files for $86M IPO	West Lafayette, Indiana, biopharmaceutical company Endocyte Inc. hopes to raise more than $86 million from an initial public offering of stock. The company that develops small-molecule drug “conjugates” to treat cancer and inflammatory dise...

Reviews 0

FAQ about Sanderling Ventures

What has the press written about Sanderling Ventures?

Parsers VC has collected 19 articles mentioning Sanderling Ventures, among them “No catheter, no cuff: FDA clears Sotera Wireless’ continuous noninvasive blood pressure technology” (Oct 10, 2013) and “BDC and FTQ Pour Major Investment into New Montreal Biomedical Fund” (Sep 5, 2013).

Is Sanderling Ventures still active?

Yes, Sanderling Ventures is active; its latest activity on Parsers VC dates from Nov 26, 2016.